[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592569":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":56,"collaborators":25,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":25,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":80,"overallStatus":39,"whyStopped":25,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Uşak University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Diabetic cataract patients","EXPERIMENTAL","Collection of aqueous humor during cataract surgery in non-diabetic patients and study of DEL1 and IL 17",[13,14],"Diagnostic Test: Del 1","Diagnostic Test: IL 17",{"label":16,"type":17,"description":11,"interventionNames":18},"Non-diabetic cataract patients","SHAM_COMPARATOR",[13,14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","Del 1","During cataract surgery, approximately 0.1-0.2 mL of aqueous humor will be sampled with a sterile 27 gauge syringe before viscoelastic is introduced into the anterior chamber. DEL 1 will be analyzed by ELISA",[9,16],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"IL 17","During cataract surgery, approximately 0.1-0.2 mL of aqueous humor will be sampled with a sterile 27 gauge syringe before viscoelastic is introduced into the anterior chamber. IL 17 levels will be analyzed by ELISA",[9,16],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Suzan Dogruya","CONTACT","+905322270732","sdogruya@hotmail.com",[37],{"facility":38,"status":39,"city":40,"state":40,"zip":41,"country":42,"countryCode":25,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Uşak Training and Research Hospital","RECRUITING","Uşak","64000","Turkey (Türkiye)",{"type":44,"coordinates":45},"Point",[46,47],29.4058,38.67351,{"lat":47,"lon":46},[50,53],{"name":51,"role":33,"phone":52,"phoneExt":25,"email":35},"Suzan Doğruya","05322270732",{"name":54,"role":55,"phone":25,"phoneExt":25,"email":25},"Rahşan Ilıkçı Sağkan","SUB_INVESTIGATOR",{"type":57,"investigatorFullName":32,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Assistant professor","100592569","evaluation-of-aqueous-humor-del-1-and-il-17-levels-in-diabetic-cataract-patients-100592569",false,"NCT06995131","Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients","DEL-1 and IL-1","Inclusion Criteria:\n\n* Cataract diagnosed and surgery planned\n* Patients without any other ocular pathology other than cataract.\n* Type 2 DM for at least 5 years in the diabetic group\n\nExclusion Criteria:\n\n* Patients with previous intraocular surgery\n* Those with inflammatory eye diseases (e.g. uveitis)\n* Those with autoimmune diseases or systemic inflammatory diseases\n* Those receiving local or systemic steroid therapy\n* Those with severe systemic disease (e.g. advanced renal failure, malignancy)",true,"ALL","50 Years","80 Years",{"count":71,"type":72},60,"ESTIMATED","INTERVENTIONAL",[75],"NA","By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related inflammatory processes in the eye.",[78,79],"Diabetic Group (n=30)","Non-diabetic Group",[81,82,83,22,84],"Diabetes Mellitus","cataract","aqueous humor","IL17","2025-06-03",{"date":87,"type":88},"2025-06-05","ACTUAL",{"date":90,"type":88},"2025-05-01",{"date":92,"type":72},"2025-08-15",{"name":5,"class":6},1]